Document is current
Any future updates will be listed below
-
Authors
Desclides, Manon
Ozenne, Valéry
Bour, Pierre
Faller, Thibaut
Machinet, Guillaume
Pierre, Christophe
Chemouny, Stéphane
Quesson, Bruno
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-IAHU04-LIRYC)
- License Information
-
More Information
Article History
Received: 18 November 2022
Accepted: 10 February 2023
First Online: 25 February 2023
Competing interests
: M Desclides, Dr. Faller, and Dr. Bour are Certis Therapeutics employees. Dr. Quesson and Dr. Ozenne are shareholders and co-founders of Certis Therapeutics. Dr. Chemouny is the CEO of Certis Therapeutics. Dr. Machinet and C Pierre are employees of ALPhANOV.
